ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,122.21
1.15%
US Tech 100
17,410.52
1.96%
다우존스 지수
38,663.81
1.15%
Bitcoin
61,770.63
4.48%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NYSE
  6. Haemonetics Corp (HAE)

  7. Haemonetics Corp (HAE) 뉴스

HAE Haemonetics Corp

93.73
0.40 (0.43%)
최종 업데이트: 01:02:00
15분 지연
기업명 주식 심볼 시장 주식 타입
Haemonetics Corp HAE NYSE 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.40 0.43% 93.73 01:02:00
개장가 저가 고가 종가 전일 종가
94.52 93.09 94.63 93.33
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
11/04/202405:58PRNUSHaemonetics Sets Date for Publishing Fourth Quarter and..
04/04/202419:30PRNUSHaemonetics Receives FDA Clearance for New TEG® 6s Global..
01/04/202421:00PRNUSHaemonetics Corporation Completes Acquisition of Attune..
05/03/202420:10EDGAR2Form 8-K - Current report
05/03/202420:00PRNUSHaemonetics Announces Definitive Agreement to Acquire Attune..
22/02/202407:57PRNUSHaemonetics to Present at Raymond James 45th Annual..
22/02/202407:55PRNUSHaemonetics to Present at Citi's 2024 Unplugged Medtech and..
14/02/202405:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/02/202407:49EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/02/202400:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/02/202420:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/02/202420:05EDGAR2Form 8-K - Current report
08/02/202420:00PRNUSHaemonetics 3rd Quarter Fiscal Year 2024 Earnings Release..
24/01/202406:13EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/01/202406:05PRNUSHaemonetics Sets Date for Publishing Third Quarter Fiscal..
12/12/202320:09EDGAR2Form 8-K - Current report
12/12/202320:00PRNUSHaemonetics Corporation Completes Acquisition of OpSens Inc.
08/12/202306:05PRNUSHaemonetics to Present at 42nd Annual J.P. Morgan Healthcare..
04/11/202305:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202320:00PRNCAOPSENS OBTIENT UNE ORDONNANCE PROVISOIRE ET DÉPOSE UNE..
02/11/202319:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202319:16EDGAR2Form 8-K - Current report
02/11/202319:00PRNUSHaemonetics 2nd Quarter Fiscal Year 2024 Earnings Release..
25/10/202305:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202305:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/10/202319:10EDGAR2Form 8-K/A - Current report: [Amend]
10/10/202319:00PRNCAOPSENS SIGNS DEFINITIVE AGREEMENT FOR ITS ACQUISITION BY..
06/10/202305:05PRNUSHaemonetics Sets Date for Publishing Second Quarter Fiscal..
19/09/202305:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/09/202305:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/09/202305:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202301:19EDGAR2Form 144 - Report of proposed sale of securities
12/09/202302:22EDGAR2Form 144 - Report of proposed sale of securities
08/09/202305:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202303:23EDGAR2Form 144 - Report of proposed sale of securities
29/08/202319:30PRNUSHaemonetics Announces European Expansion for VASCADE®..
12/08/202305:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/08/202305:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202305:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/08/202319:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202319:01EDGAR2Form 8-K - Current report
08/08/202319:00PRNUSHaemonetics 1st Quarter Fiscal Year 2024 Earnings Release..
08/08/202305:19EDGAR2Form 8-K - Current report
08/08/202305:10PRNUSDiane M. Bryant Joins Haemonetics' Board of Directors

최근 히스토리

NYSE
HAE
Haemonetics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유